KaydedilenlerDerginizi ekleyin

Dergiler / Dicle Tıp Dergisi / 2018 / Cilt: 45 - Sayı: 2

Breast Cancer Stem Cells and Iron Dependency

Meme Kanseri Kök Hücreleri ve Demir Bağımlılığı

UFUK ÖZER
Sayfa
195–200
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: Iron is an important element for maintenance of BCSCs

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: Among woman, breast cancer is the most prevalent cancer worldwide.
📊
Temel Bulgular & Veri:Methods: TPBC cell lines; BT474, HCC1954 and TNBC cell lines; MDA-MB-435, Hs578T, MDA-MB-231 were used to measure intracellular iron levels via a fluorescent probe, calcein-AM, utilizing flow cytometry.
💡
Sonuç & Katkı:Conclusion: Iron is an important element for maintenance of BCSCs
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objectives: Among woman, breast cancer is the most prevalent cancer worldwide. It is composed of various cell types that are classified into different subtypes such as triple negative breast cancer (TNBC), triple positive breast cancer (TPBC). TNBCs and TPBCs represent distinct genetic background, thereby leading to therapeutic diversity in breast cancer. It is critical to know their tumorigenic properties to overcome the diversity. Methods: TPBC cell lines; BT474, HCC1954 and TNBC cell lines; MDA-MB-435, Hs578T, MDA-MB-231 were used to measure intracellular iron levels via a fluorescent probe, calcein-AM, utilizing flow cytometry. Breast cancer stem cells (BCSCs) are detected by surface expression of CD44+/CD24- markers in the lines. Results: Here, it has shown that TNBCs have higher basal levels of iron and population of BCSCs than TPBCs. Iron addition provides enrichment of BCSCs in TPBCs. Conclusion: Iron is an important element for maintenance of BCSCs

Abstract

ÖzGiriş: Meme kanseri dünya çapında kadınlarda görülen en yaygın kanserdir. Üçlü negatif ve meme kanseri (TNBC) ve üçlü pozitif meme kanseri (TPBC) gibi farklı alt tiplerde kategorilere ayrılan heterojen bir hastalıktır. TNBC’ler ve TPBC’ler farklı genetik altyapıları gösterirler ve bu meme kanserinde terapötik çeşitliliğe yol açar. Bu çeşitliliğin üstesinden gelmek için hücrelerin tümörijenik özelliklerini bilmek çok önemlidir. Yöntemler: Flowsitometriden faydalanılarak floresan bir prob olan calcein-AM yardımıyla hücreiçi demir seviyelerini ölçmek için TPBC hücre hatları BT474, HCC1954 ve TNBC hücre hatları MDA-MB-435, MDA-MB-231, Hs578T kullanıldı. Meme kanseri kök hücreleri (BCSCs) hücre hatlarında CD44+/CD24- ‘ün yüzey ekspresyonu ile tanımlandı. Bulgular: Burada TNBC’lerinTPBC’lerden daha fazla bazal demire ve BCSC’ye sahip olduğu gösterilmiştir. Demir ilavesi TPBC’lerde BCSC populasyonunun artmasını sağlamıştır. Sonuç: Demir BCSC’lerin canlılığını idame etmesi bakımından önemli bir elementtir.

🔖

Bu Makaleye Atıf Yap

ÖZER, U. (2018). Breast Cancer Stem Cells and Iron Dependency. Dicle Tıp Dergisi, Cilt: 45 - Sayı: 2, 195–200. https://ajindex.com/articles/193381

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (17)

  1. Raggi C, Gammella E, Correnti M, et al. Dysregulation of iron metabolism in cholangiocarcinoma stem-like cells. Sci Rep. 2017;7:1-12.
  2. Ninomiya T, Ohara T, Noma K, et al. Iron depletion is a novel therapeutic strategy to target cancer stem cells. Oncotarget. 2017;8:98405-416.
  3. Nishitani S, Noma K, Ohara T, et al. Iron depletioninduced downregulation of N-cadherin expression inhibits invasive malignant phenotypes in human esophageal cancer. Int J Oncol. 2016;49:1351–9.
  4. Urano S, Ohara T, Noma K, et al. Iron depletion enhances the effect of sorafenib in hepatocarcinoma. Cancer BiolTher. 2016;17:648–56.
  5. Ohara T, Noma K, Urano S, et al. A novel synergistic effect of iron depletion on antiangiogenic cancer therapy. Int J Cancer. 2013;132:2705–13.
  6. Cui J, Hollmen M, Li L, et al. New use of an old drug: nhibition of breast cancer stem cells by benztropinemesylate. Oncotarget. 2017;8:1007-1022
  7. Finn RS, Dering J, Ginther C, et al. Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basaltype/“ triple-negative” breast cancer cell lines growing in vitro. Breast Cancer Res Treat. 2007;105:319-26.
  8. Gupta PB, Onder TT, Jiang G, et al. Identification of selective inhibitors of cancer stem cells by highthroughput screening. Cell. 2009;138:645-59.
  9. Sun M, Lou W, Chun JY, et al. Sanguinarine suppresses prostate tumor growth and inhibits survivinexpression. Genes Cancer. 2010;1:283-92.
  10. Marx C, Berger C, Xu F, et al. Validated highthroughput screening of drug-like small molecules for inhibitors of ErbB2 transcription. Assay Drug Dev Technol. 2006;4:273-84.
  11. Hamai A, Caneque T, Müller S, et al. An iron hand over cancer stem cells. Autophagy. 2017;13:1465-6.
  12. Chekhun VF, Lukianova NY, Chekhun SV, et al. Association of CD44+CD24-/low with markers of aggressiveness and plasticity of cell lines and tumors of patients with breast cancer. ExpOncol. 2017;39:203-11
  13. Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer. 2008;8:755-68.
  14. Nguyen LV, Vanner R, Dirks P, Eaves CJ. Cancer stem cells: an evolving concept. Nat Rev Cancer. 2012;12:133-43.
  15. Karnoub AE, Dash AB, Vo AP, et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature. 2007;449:557-63.
  16. Wahba HA, El-Hadaad HA. Current approaches in treatment of triple-negative breast cancer. Cancer Biol Med. 2015;12:106-16.
  17. Dai X, Cheng H, Bai Z, Li J. Breast cancer cell line classif